NCT00147264View on ClinicalTrials.gov

Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

January 31, 2006

Study Completion Date

November 30, 2006

Conditions
Metabolic Syndrome X
Interventions
DRUG

Telmisartan (Micardis®) vs. Placebo

BEHAVIORAL

Low-Glycemic Index Diet vs. Control Diet

Trial Locations (1)

L8L 2X2

Hamilton Health Sciences - Cardiovascular Obesity Research and Management Center, Hamilton

Sponsors
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Heart and Stroke Foundation of Canada

OTHER

collaborator

Medtronic

INDUSTRY

lead

McMaster University

OTHER